WATERS CORP /DE/ (WAT): M&A transaction — Waters completes $1.36B cash acquisition of Wyatt Technology

WATERS CORP /DE/

Total purchase price of $1.36B in cash, financed via balance sheet and credit facility.
Wyatt Technology generates >80% revenue from large molecule applications, accelerating Waters' bioanalytical business.
Deal expected to be accretive to adjusted EPS from Q1 2024; >$70M annual revenue synergies by year five.
Addressable market for cell/gene therapies projected at $1.8B with 10-12% annual growth.
Transaction expected immediately accretive to revenue growth and margin profile.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

WATERS CORP /DE/ completed an acquisition involving Wyatt Technology LLC for $1,360,000,000 in cash (closed 2023-05-16).

Action: acquisition
Counterparty: Wyatt Technology LLC
Consideration: $1,360,000,000 in cash
Closing: 2023-05-16

Exact text from the filing

and Geofrey Wyatt in his capacity as representative of the Shareholders (“Representative”). The total purchase price payable to the Shareholders of Wyatt Technology was $1,360,000,000 in cash, as adjusted for closing cash, closing indebtedness, closing working capital and closing transaction expenses, in each case as set forth in the Purchase Agreement (the

View on SEC.gov

Browse all m&a transactions →

WATERS CORP /DE/ filing history →

Source: SEC EDGAR

accession 0001193125-23-146126

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.